Glenn Sblendorio – Biography
Last update: April 3, 2026Executive profile
Glenn was President at Medicines, and Treasurer at Targanta Therapeutics. Glenn Sblendorio joined Biomarin Pharmaceutical in 2026.
Glenn Sblendorio is currentlyChairman of the Board at Mineralys Therapeutics - View - Mineralys Therapeutics org chart
Director at 4D Molecular Therapeutics - View - 4D Molecular Therapeutics org chart
Director at Amicus Therapeutics - View - Amicus Therapeutics org chart
Create your alert
to follow the career of Glenn Sblendorio.
Education
Glenn Sblendorio has a Bachelor of Business Administration and Accounting from Pace University in 1978 and a Master of Business Administration in Finance from Fairleigh Dickinson University in 1985.
They have also studied at Pace University :
Find more alumni from Pace University
They have also studied at Fairleigh Dickinson University :
Find more alumni from Fairleigh Dickinson University
More about Glenn Sblendorio
Selected links
Do you need to know more about Glenn Sblendorio? More results.
Participate
Social media
- Glenn Sblendorio on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Glenn Sblendorio
The colleagues of Glenn Sblendorio
Company Colleagues
- At Mineralys Therapeutics, Glenn Sblendorio has 27 colleagues including Jon Congleton (CEO), Daphne Karydas (Director)…
- At 4D Molecular Therapeutics, Glenn Sblendorio has 32 colleagues including David Kirn (President), Susannah Gray (Director)…
- At Amicus Therapeutics, Glenn Sblendorio has 29 colleagues including Bradley Campbell (CEO & President), Margaret McGlynn (Director)…
Industry Colleagues
- In the Biotechnology industry, Glenn Sblendorio has 35,760 colleagues in 2,407 companies located in 42 countries. 16,856 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Glenn Sblendorio.
Get in Touch
Here are a few tips for establishing great contacts.
and ask for Glenn Sblendorio.
